by Kevin Robb | Oct 14, 2022
My heart is pounding, and my islets are secreting. Maybe it’s my fifth cup of sugary coffee kicking in, or maybe they’ve been inspired by the plenary session I’m recalling. While the former is more likely, I toy with the idea of the latter. In the “Clinical...
by Sara M. Nolte | Sep 21, 2022
We (or maybe it’s just me) talk about cancer immunotherapy around here A LOT. It’s hard not to when there are so many new advancements in this field of cancer research! I thought it was time to provide a guide to cancer immunotherapy, highlighting some of the more...
by Cal Strode | Aug 17, 2022
Launched in June of 2015, ExCellThera is a clinical-stage biotechnology company making strides in developing robust and cost-effective processes for growing blood stem cells for therapeutic use, backed by award-winning proprietary technology. The company was founded...
by Krystal Jacques | Jul 28, 2022
I was telling a friend about how sex determination could be an interesting topic for my next blog and he responded asking, “Don’t we already know everything about sex determination?” So I asked an expert: Dr. Robin Lovell-Badge, the Principal Investigator of a stem...
by Sara M. Nolte | Jul 14, 2022
Almost two years ago, I wrote a post about how scientists were looking for new immunotherapies to improve immunologically “cold” tumours’ responses to existing therapies. And while the findings of that article were very promising, tumour evasion of the immune system...
by Lyla El-Fayomi | Jul 7, 2022
“Regenerative medicine news under the microscope” is a monthly feature highlighting big stories in stem cell research. I sample the latest and greatest findings in recent press and package them into a single post. In this double issue, I cover a gene therapy for...
Comments